Skip to main content
TTrialFinder
TrialFinder is for informational purposes only and does not provide medical advice. Always talk to your doctor.
RECRUITINGPhase 1 / Phase 2INTERVENTIONAL

A Study to Assess Safety and Efficacy of Surgical Implant of RNDP-001 in Patients With Idiopathic Parkinson's Disease

A Phase 1b/2a Study Assessing the Safety and Efficacy of Intraputamenal Dopaminergic Stem Cell Transplants in Patients With Idiopathic Parkinson's Disease

Important: This information is not medical advice. Talk to your doctor about whether a clinical trial is right for you.

About This Trial

This clinical trial is designed to test the safety and tolerability of the study intervention, RNDP-001, which will be implanted into the brain of study participants during a surgical procedure.

Who May Be Eligible (Plain English)

Who May Qualify: - Diagnosis of idiopathic Parkinson's disease consistent with the Movement Disorders Society Clinical Criteria - Age 45 to 75 - Medically stable to undergo a surgical procedure Who Should NOT Join This Trial: - Known Parkinson's disease gene mutation or variant - Previous infusion therapy or surgery for Parkinson's disease - History of allergic reaction or intolerance to an immunotherapeutic agent - Contraindication to MRI - Clinically significant medical conditions likely to interfere with the surgical procedure or study assessments Always talk to your doctor about whether this trial is right for you.

Original Eligibility Criteria

View original clinical language
Inclusion Criteria: * Diagnosis of idiopathic Parkinson's disease consistent with the Movement Disorders Society Clinical Criteria * Age 45 to 75 * Medically stable to undergo a surgical procedure Exclusion Criteria: * Known Parkinson's disease gene mutation or variant * Previous infusion therapy or surgery for Parkinson's disease * History of allergic reaction or intolerance to an immunotherapeutic agent * Contraindication to MRI * Clinically significant medical conditions likely to interfere with the surgical procedure or study assessments

Treatments Being Tested

BIOLOGICAL

RNDP-001

Stem cells

DEVICE

Syringe Front-Loading Device

Delivers the stem cells

Locations (3)

University of Arizona
Tucson, Arizona, United States
Keck Medical Center of University of Southern California
Los Angeles, California, United States
The Ohio State University Wexner Medical Center
Columbus, Ohio, United States